These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms. Bodey B; Psenko V; Lipsey AL; Kaiser HE Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612 [TBL] [Abstract][Full Text] [Related]
23. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932 [TBL] [Abstract][Full Text] [Related]
24. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866 [TBL] [Abstract][Full Text] [Related]
25. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites. Elg SA; Hill RB; Heldman L; Ramakrishnan S Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933 [TBL] [Abstract][Full Text] [Related]
26. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions. Liam CK; Lim KH; Wong CM Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486 [TBL] [Abstract][Full Text] [Related]
27. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413 [TBL] [Abstract][Full Text] [Related]
28. Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer. Barton DP; Blanchard DK; Wells AF; Nicosia SV; Roberts WS; Cavanagh D; Djeu JY Anticancer Res; 1994; 14(3A):761-72. PubMed ID: 8074478 [TBL] [Abstract][Full Text] [Related]
29. [Interleukin-2 (IL-2) in active pulmonary tuberculosis]. Ida T; Taniai S; Makiguchi K; Otomo N; Taniguchi K; Miyazato I; Chida M; Ichioka M; Marumo F Kekkaku; 1991 Nov; 66(11):723-6. PubMed ID: 1766152 [TBL] [Abstract][Full Text] [Related]
30. Activated retinitis pigmentosa peripheral lymphocytes adhere to and alter cultured human retinal pigment epithelial cells. Williams LL; Lew HM; Shannon BT; Singley CT; Chambers RB; Davidorf FH Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2848-60. PubMed ID: 1526734 [TBL] [Abstract][Full Text] [Related]
31. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer. Sakata H; Murakami S; Hirayama R Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066 [TBL] [Abstract][Full Text] [Related]
32. Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions of patients with cancer. Domagala W; Emeson EE; Koss LG J Natl Cancer Inst; 1978 Aug; 61(2):295-300. PubMed ID: 308101 [TBL] [Abstract][Full Text] [Related]
33. A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma. Vacca A; Di Stefano R; Frassanito A; Iodice G; Dammacco F Clin Exp Immunol; 1991 Jun; 84(3):429-34. PubMed ID: 2044221 [TBL] [Abstract][Full Text] [Related]
34. Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis. Pforte A; Brunner A; Gais P; Burger G; Breyer G; Ströbel M; Häussinger K; Ziegler-Heitbrock HW Am Rev Respir Dis; 1993 Mar; 147(3):717-22. PubMed ID: 7680189 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-16 in tuberculous and malignant pleural effusions. Qin XJ; Shi HZ; Huang ZX; Kang LF; Mo WN; Wu C Eur Respir J; 2005 Apr; 25(4):605-11. PubMed ID: 15802332 [TBL] [Abstract][Full Text] [Related]
37. Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation. Lawrence EC; Holland VA; Young JB; Windsor NT; Brousseau KP; Noon GP; Whisennand HH; Debakey ME; Nelson DL Am Rev Respir Dis; 1989 Sep; 140(3):789-96. PubMed ID: 2506785 [TBL] [Abstract][Full Text] [Related]
38. Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients. Caruso C; Modica MA; Candore G; Di Giulio C; Galluzzo A; Giordano C; Di Marco P; Gebbia V; Tamone Reyes M; Citarrella P Boll Ist Sieroter Milan; 1990; 69(1):335-8. PubMed ID: 2102116 [TBL] [Abstract][Full Text] [Related]
39. Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines. Mantovani G; Macciò A; Pisano M; Versace R; Lai P; Esu S; Massa E; Ghiani M; Dessì D; Melis GB; Del Giacco GS Int J Cancer; 1997 May; 71(5):724-31. PubMed ID: 9180137 [TBL] [Abstract][Full Text] [Related]
40. Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Hoheisel G; Izbicki G; Roth M; Chan CH; Reichenberger F; Schauer J; Perruchoud AP Respiration; 1998; 65(3):183-6. PubMed ID: 9670298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]